(Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced ...
People also ask
Is ALDX a good buy?
What is ALDX stock target?
What does Aldeyra Therapeutics do?
Is Reproxalap FDA approved?
Stock Information · SEC Filings · Investor FAQs · Investor Email Alerts · About Show submenu. Corporate Overview · Leadership Team & Board of Directors.
Access Aldeyra Therapeutics Inc (ALDX) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.
A copy of our bylaws is posted on the investor relations section of our website at http://ir.aldeyra.com. All notices of proposals by stockholders, whether ...
Find annual and quearterly earnings data for Aldeyra Therapeutics, Inc. Common Stock (ALDX) including earnings per share, earnings forecasts at Nasdaq.com.
Head of Investor Relations, N/A, N/A, N/A. Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is ...
16 hours ago · A live audio webcast and slide presentation will be accessible from the “Investors & Media” section of the Aldeyra website at https://ir ...